Cidara Therapeutics, Inc.

NasdaqCM:CDTX 주식 보고서

시가총액: US$54.5m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cidara Therapeutics 관리

관리 기준 확인 2/4

Cidara Therapeutics' CEO는 Jeff Stein, Jan2014 에 임명되었습니다 의 임기는 10.42 년입니다. 총 연간 보상은 $ 1.56M, 38.1% 로 구성됩니다. 38.1% 급여 및 61.9% 보너스(회사 주식 및 옵션 포함). 는 $ 880.67K 가치에 해당하는 회사 주식의 1.6% 직접 소유합니다. 880.67K. 경영진과 이사회의 평균 재임 기간은 각각 3.6 년과 3.4 년입니다.

주요 정보

Jeff Stein

최고 경영자

US$1.6m

총 보상

CEO 급여 비율38.1%
CEO 임기10.4yrs
CEO 소유권1.6%
경영진 평균 재임 기간3.4yrs
이사회 평균 재임 기간3.4yrs

최근 관리 업데이트

Recent updates

We Think Cidara Therapeutics (NASDAQ:CDTX) Can Easily Afford To Drive Business Growth

Sep 28
We Think Cidara Therapeutics (NASDAQ:CDTX) Can Easily Afford To Drive Business Growth

Lacklustre Performance Is Driving Cidara Therapeutics, Inc.'s (NASDAQ:CDTX) 39% Price Drop

Apr 17
Lacklustre Performance Is Driving Cidara Therapeutics, Inc.'s (NASDAQ:CDTX) 39% Price Drop

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Are Reducing Their Forecasts For This Year

Mar 25
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Are Reducing Their Forecasts For This Year

We're Hopeful That Cidara Therapeutics (NASDAQ:CDTX) Will Use Its Cash Wisely

Mar 14
We're Hopeful That Cidara Therapeutics (NASDAQ:CDTX) Will Use Its Cash Wisely

Cidara spikes on $11M milestone payment from partner Mundipharma

Oct 04

Cidara begins dosing of antiviral CD388 in trial for preventing influenza

Sep 13

Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M

Aug 09

Industry Analysts Just Made A Captivating Upgrade To Their Cidara Therapeutics, Inc. (NASDAQ:CDTX) Revenue Forecasts

Dec 17
Industry Analysts Just Made A Captivating Upgrade To Their Cidara Therapeutics, Inc. (NASDAQ:CDTX) Revenue Forecasts

Rainbows and Unicorns: Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Just Became A Lot More Optimistic

Aug 17
Rainbows and Unicorns: Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Just Became A Lot More Optimistic

Is Cidara Therapeutics (NASDAQ:CDTX) Weighed On By Its Debt Load?

Aug 04
Is Cidara Therapeutics (NASDAQ:CDTX) Weighed On By Its Debt Load?

Cidara Therapeutics: Rezafungin Data Could Bring Value

Jul 20

CEO 보상 분석

Jeff Stein 의 보수는 Cidara Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$36m

Dec 31 2023US$2mUS$594k

-US$23m

Sep 30 2023n/an/a

-US$35m

Jun 30 2023n/an/a

-US$15m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$1mUS$566k

-US$34m

Sep 30 2022n/an/a

-US$33m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$44m

Dec 31 2021US$2mUS$566k

-US$42m

Sep 30 2021n/an/a

-US$47m

Jun 30 2021n/an/a

-US$47m

Mar 31 2021n/an/a

-US$74m

Dec 31 2020US$1mUS$542k

-US$75m

Sep 30 2020n/an/a

-US$67m

Jun 30 2020n/an/a

-US$47m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$1mUS$526k

-US$41m

Sep 30 2019n/an/a

-US$39m

Jun 30 2019n/an/a

-US$56m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$1mUS$501k

-US$69m

Sep 30 2018n/an/a

-US$70m

Jun 30 2018n/an/a

-US$69m

Mar 31 2018n/an/a

-US$59m

Dec 31 2017US$2mUS$460k

-US$56m

보상 대 시장: Jeff 의 총 보상 ($USD 1.56M )은 US 시장( $USD 683.56K ).

보상과 수익: 회사가 수익성이 없는 동안 Jeff 의 보상이 증가했습니다.

CEO

Jeff Stein (69 yo)

10.4yrs

테뉴어

US$1,558,544

보상

Dr. Jeffrey L. Stein, Ph D., also known as Jeff, has been the Chief Executive Officer, President and Executive Director of Cidara Therapeutics, Inc. since January 2014. Dr. Stein served as Principal Financ...

리더십 팀

이름위치테뉴어보상소유권
Jeffrey Stein
President10.4yrsUS$1.56m1.6%
$ 869.0k
Shane Ward
Chief Legal Officer2.8yrsUS$929.86k0.11%
$ 61.3k
Taylor Sandison
Chief Medical Officer7.8yrsUS$884.09k0.24%
$ 131.6k
Kevin Forrest
Founder and Chief Strategy Officerno dataUS$613.24k데이터 없음
Preetam Shah
CFO, Chief Business Officer & Principal Accounting Officer2.8yrsUS$683.71k0.16%
$ 89.7k
Allison Lewis
Senior Vice President of People & Culture3.4yrs데이터 없음데이터 없음
Leslie Tari
Chief Scientific Officer5.3yrsUS$1.39m0.15%
$ 79.7k
Nicole Davarpanah
Senior VP of Translational Research & Developmentless than a year데이터 없음데이터 없음

3.4yrs

평균 재임 기간

51.5yo

평균 연령

경험이 풍부한 관리: CDTX 의 관리팀은 경험 ( 3.6 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Jeffrey Stein
President10.4yrsUS$1.56m1.6%
$ 869.0k
Daniel Burgess
Independent Chairman of the Board10.2yrsUS$126.84k0.0033%
$ 1.8k
Theodore Schroeder
Independent Director10.2yrsUS$98.84k0%
$ 0
Bonnie Bassler
Independent Director3.4yrsUS$86.84k0.00033%
$ 179.7
Carin Canale-Theakston
Independent Director3.4yrsUS$82.34k0%
$ 0
Chrysa Mineo
Independent Director6.3yrsUS$91.34k0%
$ 0
Stephen Schoenberger
Member of the Scientific Advisory Boardless than a year데이터 없음데이터 없음
Perry Nisen
Member of the Scientific Advisory Board2.1yrs데이터 없음데이터 없음
Ryan Spencer
Independent Directorless than a year데이터 없음데이터 없음
James Merson
Independent Directorless than a year데이터 없음데이터 없음
Laura Tadvalkar
Independent Directorless than a year데이터 없음데이터 없음

3.4yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: CDTX 의 이사회는 경험(평균 재직 기간 3.4 년)으로 간주됩니다.